MedTrace Logo

Monitoring Strategies for the Detection of Atrial Fibrillation in Patients with Cryptogenic Stroke

NCT04644679 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 49

Last updated 2024-11-21

No results posted yet for this study

Summary

Randomized clinical trial comparing two monitoring strategies, the use of a 48-hour Holter (routine care branch) and an event recorder for 7 days (intervention branch).

Patients admitted for cryptogenic stroke will be included. Enrollment and randomization of patients will be carried out during the index case hospitalization, while follow-up will be done on an outpatient basis until day 7.

Conditions

Interventions

DIAGNOSTIC_TEST

7-day electrocardiographic monitoring

7-day external electrocardiographic monitoring

DIAGNOSTIC_TEST

48-hr electrocardiographic monitoring

48-hr external electrocardiographic monitoring

Sponsors & Collaborators

  • Hospital Italiano de Buenos Aires

    lead OTHER

Principal Investigators

  • Gustavo Maid, MD · Hospital Italiano de Buenos Aires

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-02
Primary Completion
2021-09-30
Completion
2021-10-07
FDA Device
Yes

Countries

  • Argentina

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04644679 on ClinicalTrials.gov